A new molecular pathway that inhibits the myelination of neurons in the brains of patients with the rare genetic disorder tuberous sclerosis complex (TSC) has been discovered by researchers. The study suggests new ways to treat some of the neurological symptoms associated with TSC, including autism and epilepsy.